You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Raw chart and full-history price indicators begin at the captured split on Jul 8, 2022; bars on opposite sides are not compared.
Torrent Pharma reported Q2 revenues of 4979 crores, up by 51%, and operating EBITDA of 1666 crores, up by 54%, with an operating EBITDA margin of 33.5%. Management expects H2 to be a little higher than 33.5%.
Illustrative technical + ownership context — a signal mix, not investment advice.
Raw-price comparisons begin at the captured split on Jul 8, 2022; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XNSE:TORNTPHARM | +0.4% | +3.2% | +5.8% | +2.5% | +22.8% |
Share classes and depositary receipts can have different prices and dividends.
| Ex-dividend date | Amount per share |
|---|---|
| 2026-05-29 | 9.00 INR |
| 2026-02-18 | 29.00 INR |
| 2025-06-20 | 6.00 INR |
| 2025-01-31 | 26.00 INR |
| 2024-06-21 | 6.00 INR |
| 2024-02-12 | 22.00 INR |
| 2023-06-23 | 8.00 INR |
| 2023-02-03 | 14.00 INR |
| 2022-06-03 | 11.50 INR |
| 2022-02-02 | 12.50 INR |
| 2021-06-17 | 7.50 INR |
| 2021-02-15 | 10.00 INR |
| 2020-03-18 | 16.00 INR |
| 2019-06-13 | 2.00 INR |
| 2019-02-06 | 6.50 INR |
| 2018-06-18 | 2.50 INR |
| 2018-02-15 | 4.50 INR |
| 2017-06-19 | 2.00 INR |
| 2017-02-10 | 5.00 INR |
| 2016-03-16 | 7.50 INR |
No upcoming investor events are listed for this company yet.
